DE69231063D1 - Lysate von keratinozyten zur verwendung als heilmittel für wunden. - Google Patents

Lysate von keratinozyten zur verwendung als heilmittel für wunden.

Info

Publication number
DE69231063D1
DE69231063D1 DE69231063T DE69231063T DE69231063D1 DE 69231063 D1 DE69231063 D1 DE 69231063D1 DE 69231063 T DE69231063 T DE 69231063T DE 69231063 T DE69231063 T DE 69231063T DE 69231063 D1 DE69231063 D1 DE 69231063D1
Authority
DE
Germany
Prior art keywords
keratinocytes
pellet
lerates
wounds
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231063T
Other languages
English (en)
Other versions
DE69231063T2 (de
Inventor
Bossuyt Hans Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Publication of DE69231063D1 publication Critical patent/DE69231063D1/de
Application granted granted Critical
Publication of DE69231063T2 publication Critical patent/DE69231063T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69231063T 1991-11-20 1992-11-19 Lysate von keratinozyten zur verwendung als heilmittel für wunden. Expired - Fee Related DE69231063T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91403137 1991-11-20
PCT/EP1992/002657 WO1993010217A1 (en) 1991-11-20 1992-11-19 New cultures of keratinocytes, process for their preparation and their use as wound healing substances

Publications (2)

Publication Number Publication Date
DE69231063D1 true DE69231063D1 (de) 2000-06-21
DE69231063T2 DE69231063T2 (de) 2001-01-11

Family

ID=8208640

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69233558T Expired - Fee Related DE69233558T2 (de) 1991-11-20 1992-11-19 Keratinozyt-abstammende Granulate zur Verwendung als wundheilendes Mittel
DE69231063T Expired - Fee Related DE69231063T2 (de) 1991-11-20 1992-11-19 Lysate von keratinozyten zur verwendung als heilmittel für wunden.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69233558T Expired - Fee Related DE69233558T2 (de) 1991-11-20 1992-11-19 Keratinozyt-abstammende Granulate zur Verwendung als wundheilendes Mittel

Country Status (11)

Country Link
US (2) US6126935A (de)
EP (2) EP0615545B1 (de)
JP (1) JP3311351B2 (de)
AT (2) ATE193057T1 (de)
CA (1) CA2123683C (de)
DE (2) DE69233558T2 (de)
DK (2) DK0615545T3 (de)
ES (2) ES2149779T3 (de)
GR (1) GR3034195T3 (de)
HK (1) HK1027022A1 (de)
WO (1) WO1993010217A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3377354B2 (ja) * 1995-12-25 2003-02-17 株式会社メニコン 人工皮膚
US5935850A (en) * 1996-09-30 1999-08-10 The Research Foundation Of State University Of New York Model for cell migration and use thereof
US6274163B1 (en) * 1998-04-08 2001-08-14 Keraplast Technologies, Ltd. Keratinous protein material for wound healing applications and method
EP1053309B1 (de) * 1998-02-13 2006-11-22 The Wistar Institute Zusammensetzungen und methoden zur wundheilung
US7846465B1 (en) * 1999-05-28 2010-12-07 Fibrocell Science, Inc. Method of using autologous fibroblasts to promote healing of wounds and fistulas
US6270791B1 (en) 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
AUPR298901A0 (en) * 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US6623733B1 (en) * 2001-06-27 2003-09-23 Advanced Cardiovascular Systems, Inc. Methods for treatment of vascular disease and device for preparation of an autologous composition for treating vascular disease
DE10151296A1 (de) 2001-10-17 2003-04-30 Boehringer Ingelheim Pharma Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
US8394371B2 (en) 2002-02-11 2013-03-12 Neocutis Sa Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
CA2504801A1 (en) * 2002-12-03 2004-06-17 Innogenetics N.V. Pharmaceutical compositions of cell lysate and processes for the production and use thereof
GB0304918D0 (en) * 2003-03-05 2003-04-09 Celltran Ltd Cell culture
US20070248574A1 (en) * 2004-01-27 2007-10-25 Miller Freda D Methods of Making and Using Skin-Derived Stem Cells
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
GB2444232A (en) * 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
AU2008282931A1 (en) * 2007-07-27 2009-02-05 Immuneregen Biosciences, Inc. Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof
WO2009051622A2 (en) * 2007-10-12 2009-04-23 Immuneregen Biosciences, Inc. Methods for stimulating fibroblast proliferation using substance p analogs
JP5632383B2 (ja) * 2008-11-04 2014-11-26 ストラタテック コーポレーション 即時使用のための乾燥され、放射線照射された皮膚同等物
US20130230494A1 (en) * 2010-05-25 2013-09-05 The Research Foundation Of State University Of New York Cellular Preparations For Wound Management
US10344260B2 (en) * 2011-09-30 2019-07-09 Amorepacific Corporation Melanocyte or progenitor cell thereof adapted to keratinocyte, and preparation method thereof
KR101410065B1 (ko) * 2011-12-09 2014-06-27 테고사이언스 (주) 세포의 유용물질을 상온에서 안정하게 보존하는 방법
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
EP3132809A1 (de) 2015-08-21 2017-02-22 Bioskinco GmbH Zusammensetzung und produkte mit alterungszellen zur geweberegeneration
MX2022006590A (es) * 2019-12-02 2022-09-19 Avant Meats Company Ltd Metodos de produccion de carne por cultivo celular in vitro.
US11306342B2 (en) 2019-12-02 2022-04-19 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof
US20220333148A1 (en) * 2021-04-09 2022-10-20 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
LU73893A1 (de) * 1975-11-28 1977-06-09
US4299819A (en) * 1979-01-02 1981-11-10 Sloan-Kettering Institute For Cancer Research Process for treating burn victims
US4254226A (en) * 1979-09-13 1981-03-03 Sloan Kettering Institute For Cancer Research Process for growing human epidermal cells in tissue culture
US4304866A (en) * 1979-11-14 1981-12-08 Massachusetts Institute Of Technology Transplantable sheets of living keratinous tissue
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US5000963A (en) * 1983-06-14 1991-03-19 Hefton John M Method of treating the skin using human epidermal sheets
US4673649A (en) * 1983-07-15 1987-06-16 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
US4940666A (en) * 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
EP0215274B1 (de) * 1985-08-14 1993-03-31 Memorial Hospital for Cancer and Allied Diseases Epidermiszellenextrakte und Verfahren zur Verbesserung der Wundheilung und zur Regenerierung der Epidermis
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
JPH0687301B2 (ja) * 1986-01-24 1994-11-02 富士写真フイルム株式会社 磁気記録媒体の製造方法
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
US4888291A (en) * 1987-06-19 1989-12-19 President And Fellows Of Harvard College Human epithelium originating from cell cultures
IT1207525B (it) * 1987-06-23 1989-05-25 Ist Naz Ric Sul Cancro Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
JPH01256330A (ja) * 1988-04-04 1989-10-12 Zenkoku Nogyo Kyodo Kumiai Rengokai ハイブリッド稲の種子生産方法
CA2000181A1 (en) * 1988-10-14 1990-04-14 Chung-Faye Chao Process for producing cultured epidermal sheet, product and method of use
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
US5262298A (en) * 1989-05-12 1993-11-16 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production
CA2018228C (en) * 1989-06-05 1996-02-27 Nancy L. Parenteau Cell culture systems and media
US5130142A (en) * 1990-10-31 1992-07-14 The Practer & Gamble Company Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor

Also Published As

Publication number Publication date
EP0970701A3 (de) 2001-12-05
DK0970701T3 (da) 2006-03-06
EP0970701A2 (de) 2000-01-12
JPH07501214A (ja) 1995-02-09
GR3034195T3 (en) 2000-11-30
EP0970701B1 (de) 2005-10-26
DE69233558T2 (de) 2006-07-27
ATE193057T1 (de) 2000-06-15
ES2149779T3 (es) 2000-11-16
DK0615545T3 (da) 2000-10-30
ES2252893T3 (es) 2006-05-16
JP3311351B2 (ja) 2002-08-05
DE69233558D1 (de) 2005-12-01
US6126935A (en) 2000-10-03
HK1027022A1 (en) 2001-01-05
ATE307599T1 (de) 2005-11-15
US5866167A (en) 1999-02-02
EP0615545B1 (de) 2000-05-17
DE69231063T2 (de) 2001-01-11
EP0615545A1 (de) 1994-09-21
WO1993010217A1 (en) 1993-05-27
CA2123683C (en) 2007-10-30
CA2123683A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
DE69231063D1 (de) Lysate von keratinozyten zur verwendung als heilmittel für wunden.
DE60228460D1 (de) Verfahren zur Herstellung und Reinigung von Erythropoietin
DK0389063T4 (da) Fremgangsmåde til isolering af nukleinsyre
AU641488B2 (en) Human hematopoietic stem cell
DE69028514T2 (de) Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
ATE309267T1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
DE69102651T2 (de) Proteaseresistenter pdgf und dessen verwendungen.
DE69530409D1 (de) Epithelzellen enthaltendes biomaterial und ihre verwendung als transplantat
DK1235901T3 (da) Fremgangsmåde til fremstilling af celletransplantater
ATE227995T1 (de) Verwendung von pseudopterosin zur förderung der wundheilung
WO2001005942A3 (en) Improved keratinocyte culture and uses thereof
DE69230879T2 (de) Verwendung von Hepatocyten-Wachstumsfaktoren zur Herstellung eines Vermehrungssystems für Hematopoietische Stammzellen
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
DE3485773T2 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
Reid et al. Modulation of cellular growth in vitro by growth factor inactivation with selenium covalently attached to an inert cellulose matrix
FR2585722B1 (fr) Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees
DE29722814U1 (de) Fermenter zur Behandlung einer organischen Masse, insbesondere zur Erzeugung von Biogas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: JANNIG & REPKOW PATENTANWAELTE, 86199 AUGSBURG

8339 Ceased/non-payment of the annual fee